These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6186038)

  • 1. [Changes in fibrinolysis in liver cirrhosis].
    Fontcuberta J; Borrell M; Felez J; Elez I; López M; Remacha A; Rutllant ML
    Sangre (Barc); 1982; 27(4-B):727-36. PubMed ID: 6186038
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural protease inhibitors to fibrinolysis in liver diseases.
    Arnman R; Gyzander E; Hedner U; Olsson R; Teger-Nilsson AC
    Hepatogastroenterology; 1980 Aug; 27(4):254-8. PubMed ID: 6162766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood coagulation and fibrinolysis inhibitory factors].
    Imaoka S; Sasaki Y; Terasawa T
    Rinsho Byori; 1985 Jun; Spec No 63():55-61. PubMed ID: 2413229
    [No Abstract]   [Full Text] [Related]  

  • 4. ACL automated method for plasma inhibitors.
    Creter D
    Haematologica; 1990; 75(6):582. PubMed ID: 1711504
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolysis as a cause of coagulopathy in patients with chronic diffuse diseases of the liver].
    Serov NA; Sukhanov VA; Podymova SD
    Klin Med (Mosk); 1991 Apr; 69(4):73-5. PubMed ID: 1865658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo.
    Noda Y; Nakamura M; Sasaki M; Kosugi T
    Auris Nasus Larynx; 1986; 13 Suppl 1():S75-9. PubMed ID: 2429647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
    Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
    Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibitors of serum proteinases].
    Jendryczko A; Drózdz M
    Wiad Lek; 1985 Dec; 38(23):1654-9. PubMed ID: 2421489
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural inhibitors of the coagulation system.
    Messmore HL
    Semin Thromb Hemost; 1982 Oct; 8(4):267-75. PubMed ID: 6184781
    [No Abstract]   [Full Text] [Related]  

  • 10. [The blood coagulation system in progressive systemic scleroderma].
    Sica S; Paoletti S; Storti S; Pagano L; Marra R; Garcovich A
    Minerva Med; 1987 Dec; 78(24):1831-4. PubMed ID: 2448705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disorders of coagulation/fibrinolysis and bleeding tendency].
    Endo T; Amemiya N; Kume S
    Nihon Rinsho; 1994 Jan; 52(1):119-23. PubMed ID: 8114280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the fibrinolytic system in patients with fulminant liver failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic abnormalities of the fibrinolytic system.
    Aoki N
    Prog Clin Biol Res; 1981; 72():229-47. PubMed ID: 7199719
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of dysfibrinogenemia and disorders of fibrinolysis in the pathogenesis of hemostatic pathology in liver cirrhosis].
    Buevich EI
    Ter Arkh; 1987; 59(2):104-9. PubMed ID: 3576461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.
    Rao AK; Schmaier AH; Colman RW
    Pathobiol Annu; 1982; 12():35-64. PubMed ID: 6186978
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitors of fibrinolysis in saliva after oral surgery measured by enzymic and immunological methods.
    Gersel-Pedersen N
    Int J Oral Surg; 1979 Jun; 8(3):212-21. PubMed ID: 93090
    [No Abstract]   [Full Text] [Related]  

  • 17. Mediators of fibrinolysis in orthotopic liver transplantation.
    Cheema SP; Webster NR; Dunn F; Bellamy MC
    Clin Transplant; 1996 Feb; 10(1 Pt 1):24-7. PubMed ID: 8652893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibrinolytic system in patients with congenital protein C deficiency.
    Conard J; Horellou MH; Teger-Nilsson AC; Bertina RM; Samama M
    Thromb Res; 1984 Nov; 36(4):363-7. PubMed ID: 6549234
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinolytic abnormalities following liver transplantation in patients with fulminant hepatic failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):155-9. PubMed ID: 7536112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrinolysis in liver cirrhosis].
    Levrat M; Truchot R
    Lyon Med; 1969 May; 221(18):1071-2 passim. PubMed ID: 5398702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.